InsidersTradesSigma
Total declarations
Company
▲ Purchases (10 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Wong Hing C. Director active across 1 companies, notably HCW Biologics Inc.. Cumulatively, 12 filings have been published. Total volume traded: €163k. The latest transaction was disclosed on 10 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
€3,1321,520 shares@ €2.06040.038% mcap1.9% of flow
Common Stock
SEC:0001209191-22-036395:0·
Ideal exit: 7 Mar 2023 (T+270)
€2,1591,000 shares@ €2.15920.026% mcap1.3% of flow
Common Stock
SEC:0001209191-22-035554:0·
Ideal exit: 4 Mar 2023 (T+270)
€19,4495,830 shares@ €3.33610.24% mcap24.6% of flow
Common Stock
SEC:0001209191-21-059989·
Ideal exit: 28 May 2022 (T+270)
€25,6038,000 shares@ €3.20040.31% mcap32.4% of flow
Common Stock
SEC:0001209191-21-059988·
Ideal exit: 24 May 2022 (T+270)
€19,4495,830 shares@ €3.33610.24% mcap11.9% of flow
Common Stock
SEC:0001209191-21-059989:0·
Ideal exit: 28 May 2022 (T+270)
€25,6038,000 shares@ €3.20040.31% mcap15.7% of flow
Common Stock
SEC:0001209191-21-059988:0·
Ideal exit: 24 May 2022 (T+270)
€12,7603,830 shares@ €3.33170.16% mcap16.1% of flow
Common Stock
SEC:0001209191-21-054545·
Ideal exit: 28 May 2022 (T+270)
€12,7603,830 shares@ €3.33170.16% mcap7.8% of flow
Common Stock
SEC:0001209191-21-054545:0·
Ideal exit: 28 May 2022 (T+270)
€21,2396,500 shares@ €3.26760.26% mcap26.9% of flow
Common Stock
SEC:0001209191-21-053958·
Ideal exit: 23 May 2022 (T+270)
€21,2396,500 shares@ €3.26760.26% mcap13.0% of flow
Common Stock
SEC:0001209191-21-053958:0·
Ideal exit: 23 May 2022 (T+270)
06,316,691 shares0
Common Stock
SEC:0001209191-21-048063·
06,316,691 shares0
Common Stock
SEC:0001209191-21-048063:0·
12 of 12 declarations
About Wong Hing C
Wong Hing C is a director at HCW Biologics Inc.
